University of Thessaly (UTH)
Επίδραση του ινοτρόπου παράγοντα λεβοσιμενδάνης σε ασθενείς με συστολική δυσλειτουργία της αριστερής κοιλίας σε διάφορες αιμοδυναμικές μετρήσεις
Abstract
dc:descriptionBackground: Beta-blockers, are frequently prescribed in heart failure patients, according to current guidelines. Consequently, a continuously increasing percentage of people suffering from decompensated heart failure, take a b-blocker nowadays. Positive inotropic treatment, is indicated in cases not responding to vasodilators and diuretics. In case, a patient is already on a b-blocker, usual doses of dobutamine are ineffective, and higher doses may deteriorate patient status, due to increased peripheral resistance. On the other hand, levosimendan, a newer positive inotropic agent, does not act through adrenergic receptors, as dobutamine does. Aim : To evaluate the influence of chronic b-blockade on haemodynamic parameters of patients with decompensated heart failure, treated with levosimendan Methods and Patients: 18 patients with acutely decompensated heart failure, needing inotropic treatment (8 on chronic b-blockade), were included in this study. Prerequisities for a patient to be included in the study, were to have an ejection fraction below 0.35, his or her cardiac index to be below 2.5 l/min/m2 and wedge pressure above 15 mm Hg. Ejection fraction was calculated echocardiographically, by using Simpson’s method, and cardiac index and wedge pressure by inserting a four lumen thermodilution catheter. Heart rate, arterial pressure, central venous pressure, pulmonary and peripheral resistance, were also calculated in all patients. After all the above baseline measurements had been completed, levosimendan was started intravenously, to all patients, on an initial dose of 24 γ/kg for 10 minutes, followed by an infusion of 0.1γ/kg/min for 24 hours, and all the measurements, except for the ejection fraction, were, afterwards, repeated. Haemodynamic measurements, before and after levosimendan infusion, were compared in each group (non-taking, and taking b-blocker) by using the pair t test. Results : Cardiac index and wedge pressure, significantly improved in all patients, after levosimendan infusion. In the non-taking b-blocker group, cardiac index increased by 43.8% and wedge pressure decreased by 33% (p<0.001). In the b-blocker taking group, the figures were 17.72% and 17.5% respectively (p<0.001). Statistically significant reductions, were, also, recorded in peripheral resistance, in both groups, 31% and 15% respectively (p<0.001). Similar results were recorded for the pulmonary resistance, which decreased in both groups by 44.5% and 25% respectively (p<0.001). Conclusions : Chronic treatment by a b-blocker in heart failure, does not neutralize haemodynamic improvement caused by levosimendan, in the case of acute decompensation. Consequently, levosimendan administration does not have as a prerequisite discontinuation of the b-blocker, as it happens if dobutamine is infused, instead of levosimendan.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kirlidis, Themistoklis
- Κυρλίδης, Θεμιστοκλής
Subjects
dc:subject × 20- Λεβοσιμενδάνη
- β-Αναστολείς
- Αιμοδυναμικές μετρήσεις
- Οξεία καρδιακή ανεπάρκεια
- Ινότροπα
- Καρδιακή παροχή
- Πίεση ενσφήνωσης
- Πνευμονικές αντιστάσεις
- Levosimendan
- Beta-blockers
- Haemodynamic parameters
- Decompensated heart failure
- Positive inotropic treatment
- Cardiac index
- Wedge pressure
- Pulmonary resistance
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17187